Effectiveness of 13-valent pneumococcal conjugate vaccine for prevention of invasive pneumococcal disease among children in the United States between 2010 and 2019: An indirect cohort study.

Autor: Andrejko KL; Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA. Electronic address: kandrejko@cdc.gov., Gierke R; Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA., Rowlands JV; New York State Department of Health, New York, NY, USA., Rosen JB; Bureau of Immunization, New York City Department of Health and Mental Hygiene, New York, NY, USA., Thomas A; Oregon Public Health Division, Portland, OR, USA., Landis ZQ; New Mexico Department of Health, Santa Fe, NM, USA., Rosales M; California Emerging Infections Program, Richmond, CA, USA., Petit S; Connecticut Department of Public Health, Hartford, CT, USA., Schaffner W; Department of Health Policy, Vanderbilt University School of Medicine, Nashville, TN, USA., Holtzman C; Minnesota Department of Health, St. Paul, MN, USA., Barnes M; Colorado Department of Public Health and Environment, Denver, CO, USA., Farley MM; Department of Medicine, Emory University School of Medicine and Atlanta VA Medical Center, Atlanta, GA, USA., Harrison LH; Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, USA., McGee L; Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA., Chochua S; Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA., Verani JR; Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA., Cohen AL; Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA., Pilishvili T; Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA., Kobayashi M; Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.

Publikováno v: Vaccine [Vaccine] 2024 Jun 11; Vol. 42 (16), pp. 3555-3563. Date of Electronic Publication: 2024 May 03.